These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6596879)

  • 1. [Prostatic tissue and fluid levels of DL-8280].
    Kumon H; Furukawa M; Mizuno A; Miyata K; Akazawa N; Ohmori H; Katayama Y; Akaeda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1297-305. PubMed ID: 6596879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracamera penetration of ofloxacin in man].
    Bron A; Talon D; Delbosc B; Estavoyer JM; Kaya G; Royer J
    J Fr Ophtalmol; 1987; 10(6-7):443-6. PubMed ID: 3500972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method.
    Claes R; Dusart Y; Dupont JC; Jeanbaptiste B; Podoor M; Douchamps J
    Infection; 1986; 14 Suppl 4():S263-5. PubMed ID: 3469159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
    Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
    J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
    Verho M; Malerczyk V; Dagrosa E; Korn A
    Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
    Nawishy S; Moukhtar I; Sabbour M
    Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The investigation of prostatic fluid and tissue levels of DL-8280 and clinical study of DL-8280 in acute prostatitis].
    Hara S; Nakasu H
    Kansenshogaku Zasshi; 1984 Sep; 58(9):921-31. PubMed ID: 6440924
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diffusion of an orally administered single dose of ofloxacin into human bronchial mucus].
    Morel C; Malbruny B; Vergnaud M; Benard Y; Monrocq N
    Pathol Biol (Paris); 1986 May; 34(5):353-6. PubMed ID: 3534705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.
    Naber KG; Sörgel F
    Andrologia; 2003 Oct; 35(5):331-5. PubMed ID: 14535866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentrations of new quinolone agents in serum and prostate tissue].
    Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
    Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue levels of ofloxacin in the urogenital system.
    di Silverio F; Cruciani E; Ferrone G; de Marco F; Lauretti S; Prencipe MG
    Chemioterapia; 1987 Apr; 6(2):120-3. PubMed ID: 3474078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ofloxacin concentration in human prostatic tissue after 3 days of administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jan; 35(1):187-90. PubMed ID: 2729016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.